KL
Kalaris Therapeutics Inc (KLRS)
NASDAQ·Healthcare·Biotechnology
$5.61
-6.89%
Mkt Cap $187.02M
Analyst Ratings
No recent rating data.
Price Target (3 analysts)
$21.00
Range $19.00 – $23.00
Implied Upside
+274.7%
Consensus $21.00 vs current $5.61
NASDAQ·Healthcare·Biotechnology
$5.61
-6.89%
Mkt Cap $187.02M
No recent rating data.
Price Target (3 analysts)
$21.00
Range $19.00 – $23.00
+274.7%
Consensus $21.00 vs current $5.61